Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Puma granted broad label for neratinib after FDA OK
Puma granted broad label for neratinib after FDA OK
Puma granted broad label for neratinib after FDA OK
Submitted by
admin
on July 19, 2017 - 9:31am
Source:
BioPharma Dive
News Tags:
Puma Biotechnology
neratinib
breast cancer
Nerlynx
Headline:
Puma granted broad label for neratinib after FDA OK
Do Not Allow Advertisers to Use My Personal information
